Government Action May Lead to Ouster of Drug Company CEO
This is interesting. Last year, Forest Laboratories cut a plea deal with the government stating it would pay $313 million in penalties related to investigations into the marketing of a couple of its antidepressant drugs. The plea was finalized in March.
According to The Wall Street Journal, a couple of weeks later, Forest Labs’ CEO, president, and chairman, Howard Solomon received an “intent-to-ban notice” from The Department of Health and Human Services, which would preclude him from doing business with the government.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in